Stage 3 immature human natural killer cells found in secondary lymphoid tissue constitutively and selectively express the TH17 cytokine interleukin-22

Blood

Volumn 113, Issue 17, 2009, Pages 4008-4010

  Hughes, Tiffany ^a   Becknell, Brian ^a   McClory, Susan ^a   Briercheck, Edward ^a   Freud, Aharon G ^b   Zhang, Xiaoli ^c   Mao, Hsiaoyin ^d   Nuovo, Gerard ^d   Yu, Jianhua ^d   Caligiuri, Michael A ^d  

^a THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c OHIO STATE UNIVERSITY   (United States)

^d THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD161 ANTIGEN; CD34 ANTIGEN; CD56 ANTIGEN; CD94 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 17; INTERLEUKIN 17F; INTERLEUKIN 22; INTERLEUKIN 26; MESSENGER RNA; STEM CELL FACTOR RECEPTOR; INTERLEUKIN DERIVATIVE; INTERLEUKIN-22;

ARTICLE; CELL ACTIVITY; CELL MATURATION; CELL SURFACE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOLYSIS; DEVELOPMENTAL STAGE; HUMAN; HUMAN CELL; LYMPHOID TISSUE; MUCOSAL IMMUNITY; NATURAL KILLER CELL; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TH17 CELL; CYTOLOGY; GENETICS; HELPER CELL; IMMUNOLOGY; LYMPHOPOIESIS; METABOLISM;

HUMANS; INTERLEUKIN-17; INTERLEUKINS; KILLER CELLS, NATURAL; LYMPHOID TISSUE; LYMPHOPOIESIS; PHENOTYPE; RNA, MESSENGER; T-LYMPHOCYTES, HELPER-INDUCER;

EID: 63149141854     PISSN: 00064971     EISSN: 15280020     Source Type: None    
DOI: 10.1182/blood-2008-12-192443     Document Type: Article

References (9)

1. Freud AG, Becknell B, Roychowdhury S, et al. A human CD34(+) subset resides in lymph nodes and differentiates into CD56bright natural killer cells. Immunity. 2005;22:295-304. (Pubitemid 40387472)
2. Freud AG, Yokohama A, Becknell B, et al. Evidence for discrete stages of human natural killer cell differentiation in vivo. J Exp Med. 2006;203:1033-1043.
3. Cella M, Fuchs A, Vermi W, et al. A human natural killer cell subset provides an innate source of IL-22 for mucosal immunity. Nature. 2009;457:722-725.
4. Liang SC, Tan XY, Luxenberg DP, et al. Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides. J Exp Med. 2006;203:2271-2279.
5. Wolk K, Kunz S, Witte E, Friedrich M, Asadullah K, Sabat R. IL-22 increases the innate immunity of tissues. Immunity. 2004;21:241-254. (Pubitemid 39094053)
6. Dzionek A, Sohma Y, Nagafune J, et al. BDCA-2, a novel plasmacytoid dendritic cell-specific type II C-type lectin, mediates antigen capture and is a potent inhibitor of interferon alpha/beta induction. J Exp Med. 2001;194:1823-1834. (Pubitemid 34028661)
7. Sun Z, Unutmaz D, Zou YR, et al. Requirement for RORgamma in thymocyte survival and lymphoid organ development. Science. 2000;288:2369-2373. (Pubitemid 30448162)
8. Ivanov II, McKenzie BS, Zhou L, et al. The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells. Cell. 2006;126:1121-1133. (Pubitemid 44380299)
9. Cupedo T, Crellin NK, Papazian N, et al. Human fetal lymphoid tissue-inducer cells are interleukin 17-producing precursors to RORC(+) CD127(+) natural killer-like cells. Nat Immunol. 2009;10:66-74.